We measured the kinetics of LDL-apoB in plasma to explore the underlying metabolic mechanisms associated with reported hypertriglyceridemia and changes of apoB particle number in ACCi-treated patients (8, 10, 11, 12, 14, 16). The gene discussed is APOB; the disease is hypertriglyceridemia.